When Cytochrome P450 Inhibition Becomes a Drug Designer’s Best Friend
A new review argues that cytochrome P450 inhibition, long treated as a drug-discovery liability, can be a powerful therapeutic strategy ...
A new review argues that cytochrome P450 inhibition, long treated as a drug-discovery liability, can be a powerful therapeutic strategy ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine